Flower power can still calm the masses

Feb 09, 2010

Feeling stressed? Try chamomile! This 'traditional' remedy has been around for years, but how much truth is there behind this old wives' tale?

In an evaluation for Faculty of 1000, Michael Van Ameringen and Beth Patterson draw attention to the first of chamomile for the treatment of (GAD).

The study, recently published in the Journal of Clinical Psychopharmacology, reports that "chamomile extract therapy was found to be efficacious for mild-moderate GAD".

Patients with mild-moderate GAD were included in the study and received either chamomile or . Those that received the chamomile treatment were found to have a significant change in the severity of their GAD.

Van Amerigen and Patterson comment on the results of the study, saying that they "suggest that chamomile may have modest [anti-panic] activity in patients with mild-moderate GAD and may potentially be used in those who are averse to traditional ".

These findings are important "because many individuals who suffer from GAD do not view their anxiety as a medical condition, [and, therefore,] self-diagnosis and self-medicating with alternative, over-the-counter remedies is common".

Van Amerigen and Patterson said "a big strength of this paper is that the authors took a herbal remedy and subjected it to scientific rigor unlike many 'natural' remedies which have associated claims of efficacy with no supportive data."

Explore further: Medical charity accuses US of pushing India to ease patent rules

Provided by Faculty of 1000: Biology and Medicine

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Anxiety disorders surprisingly common yet often untreated

Mar 12, 2007

A new study by researchers led by Kurt Kroenke, M.D., of the Indiana University School of Medicine and the Regenstrief Institute, Inc. reports that nearly 20 percent of patients seen by primary care physicians have at least ...

Recommended for you

Ebola vaccine not before late 2016: GSK researcher

Oct 17, 2014

An Ebola vaccine by British pharmaceuticals giant GlaxoSmithKline may not be ready for commercial use until late 2016 and should therefore not be seen as the "primary answer" to the current outbreak, a company researcher ...

Chimerix gets FDA OK to test drug for Ebola

Oct 17, 2014

(AP)—A North Carolina drugmaker plans to test its experimental antiviral drug in patients who have Ebola, after getting authorization from regulators at the Food and Drug Administration.

Esbriet, ofev approved to treat deadly lung disease

Oct 16, 2014

(HealthDay)—Two new drugs have been approved by the U.S. Food and Drug Administration to treat progressive lung scarring from an uncertain cause, medically called idiopathic pulmonary fibrosis (IPF).

FDA weighs removing bolded warning from Chantix

Oct 14, 2014

(AP)—The Food and Drug Administration will ask a panel of experts later this week whether a bold-letter warning on the anti-smoking drug Chantix should be removed based on company-supported evidence that the drug does not ...

Drug-coated balloon catheter approved

Oct 13, 2014

(HealthDay)—The first drug-coated balloon catheter designed to clear narrowed or blocked arteries in the thigh and knee has been approved by the U.S. Food and Drug Administration.

User comments : 0